文章及专著（^# 并列一作，*通讯作者）

https://scholar.google.com/citations?hl=zh-CN&user=eZMV-dEAAAAJ&view_op=list_works&sortby=pubdate

1. Guiyuan Chen, Xiangxia Li, Yu Huang, Cheng Zheng, Haopeng Fang, Qiaoyun Zhang, Ke Liu, Kecheng Wu, Qilong Zhu, Changqing Guo, Huanjun Zhu, Ruike Dai, Ying He, Qiuhong Zhu, Wenchao Zhou, Yidong Yang, Zibo Li, Kun Qu*, Bofeng Li*, Shiyan Xiao*, Shaomin Tian, Bengang Xing, Xiaoyuan Chen, Andrew Z. Wang, Yujie Xiong, Yuanzeng Min*; Platinonitrene-based radiosensitizer boosts radiotherapy and abscopal effect, Nature Biomedical Engineering, 2025, Accepted

2. Yuanzeng Min, Kyle C. Roche, Shaomin Tian, Michael J. Eblan, Karen P.McKinnon, Joseph M. Caster, Shengjie Chai, Laura E. Herring, Longzhen Zhang, Tian Zhang, Joseph M. DeSimone, Joel E. Tepper, Benjamin G. Vincent, Jonathan S. Serody and Andrew Z. Wang*. Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy. Nature nanotechnology, 2017, 12 (9), 877-882.

3. Xiangxia Li, Guiyuan Chen, Bing Hong, Changqing Guo, Huanjun Zhu, Qilong Zhu, Yuanyu Liu, Zilong Li, Lingling Li, Chao Gao, Peng Lu, Dong Qian*, Lizhen Liang*, Yujie Xiong, Yuanzeng Min*; Boronophenylalanine-Functionalized Platinum Nanozymes Sensitizing Neutron Capture Therapy, Advanced Functional Materials, 2024, 2418800, https://doi.org/10.1002/adfm.202418800

4. Wen Pan,  Yangyi Wang,  Shaomin Tian,  Xiaopeng Ma,  Yuanzeng Min*; Gemcitabine Resistant Triple Negative Breast Tumor Derived Mesoporous Silicon Nanovaccine Overcame Drug Resistance, Advanced Functional Materials, 2024, 34(45): 2405773

5. Wen Pan,  Yangyi Wang,  Guiyuan Chen,  Xiaopeng Ma*,  Yuanzeng Min*; A carrier-free nanovaccine combined with cancer immunotherapy overcomes gemcitabine resistance, Biomaterials, 2025, DOI: 10.1016/j.biomaterials.2024.122788

6. Chen Bo; Huang Ruijie; Zeng Wei; Wang Wei*; Min Yuanzeng*; Nanocodelivery of an NIR photothermal agent and an acid-responsive TLR7 agonist prodrug to enhance cancer photothermal immunotherapy and the abscopal effect, Biomaterials, 2023, 305.

7. Huang Ruijie; Zhou Peijie; Chen Bo; Zhu Yang*; Chen Xiaoyuan*; Min Yuanzeng*; Stimuli-Responsive Nanoadjuvant Rejuvenates Robust Immune Responses to Sensitize Cancer Immunotherapy, ACS Nano, 2023, 17(21): 21455-21469.

8. Chen Guiyuan; Li Xiangxia; Li Rui; Wu Kecheng; Lei Zhouhang; Dai Ruike; Roche Kyle; Wang Andrew Z.; Min Yuanzeng*; Chemotherapy-Induced Neoantigen Nanovaccines Enhance Checkpoint Blockade Cancer Immunotherapy, ACS Nano, 2023, 17(19): 18818-18831.

9. Li Rui; Hao Yuhao; Min Yuanzeng*; Platinum-Based Twin Drug Modulates Tumor-Infiltrating Immune Cells to Improve Immune Checkpoint Blockade Therapy, Journal of Medicinal Chemistry, 2023, 66(19): 13607-13621.

10. Hao Yuhao; Li Rui; Pan Wen; Tian Shaomin; Min Yuanzeng*; Platinum Twin and Triplet Drugs Improve Chemoimmunotherapy, Journal of Medicinal Chemistry, 2023, 66(17): 12225-12236.

11. Li Rui; Hao Yuhao; Roche Kyle; Chen Guiyuan; Pan Wen; Wang Andrew Z.; Min Yuanzeng*; Chemotherapy-induced nanovaccines implement immunogenicity equivalence for improving cancer chemoimmunotherapy, Biomaterials, 2023, 301: 122290. 

12. Li Rui; Hao Yuhao; Pan Wen; Wang Wei*; Min Yuanzeng*; Monophosphoryl lipid A-assembled nanovaccines enhance tumor immunotherapy, Acta Biomaterialia, 2023, 171: 482-494.

13. Su Lanhong; Pan Wen; Li Xiangxia; Zhou Xingyu; Ma Xiaopeng*; Min Yuanzeng*; Utilizing chemotherapy-induced tumor RNA nanoparticles to improve cancer chemoimmunotherapy, Acta Biomaterialia, 2023, 158(1): 698-707.

14. Su Lanhong; Hao Yuhao; Li Rui; Pan Wen; Ma Xiaopeng*; Weng Jianping; Min Yuanzeng*; Red blood cell-based vaccines for ameliorating cancer chemoimmunotherapy, Acta Biomaterialia, 2022, 154: 401-411.